Global Blood Screening Market Research Report 2021

The objective of blood screening is to detect markers of infection in order to prevent the release of infected blood and blood components for clinical use.

The global Blood Screening market was valued at US$ XX million in 2020 and is expected to reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027.
This report focuses on Blood Screening volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Blood Screening market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Blood Screening Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Reagent
Instrument

Segment by Application
Blood Bank
Hospital

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Abbott Laboratories
Abbott
Apex Biotechnology Corp.
Beckman Coulter (A Subsidiary of Danaher Corporation)
Becton, Dickinson and Company
Biomrieux
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche
Grifols
Hem